New criteria to avoid the over-diagnosis of Alzheimer’s disease

Diagnosis of Alzheimer’s disease (AD) is currently largely based on the presence of biomarkers. This may lead to a problematic over-diagnosis if this is incorrectly interpreted. To counter this problem, a global expert panel led by Hôpitaux universitaires de Genève (HUG), the University of Geneva and the Salpêtrière Hospital have drawn up recommendations.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup